NOW.US Weekly Report · 2026-W37
Overview
ServiceNow retreated 6.16% this week to close at $132.53, marking a fresh weekly low. Despite sustained double-digit revenue growth (24% YoY), the latest earnings show profit turning negative (-22.6% YoY), raising concerns about earnings quality. Simultaneously, institutional capital showed net inflows while the stock fell, alongside consistently bullish analyst ratings—a divergence suggesting market expectations are shifting.
Price Action
This week (Sept 8–11) closed at $132.53 versus the prior week’s close (Sept 4) at $141.26, a decline of 6.16%. Intraweek range was 3.12% ($134.45 high to $130.39 low), forming a “gap-down, modest recovery” pattern—the week opened around $134.72, dropped sharply to $131.11 by Tuesday, then recovered modestly but failed to reclaim Wednesday-Thursday gains. Volume contracted to 49.87M shares (avg 12.47M/day), well below the 60-day median of 15-20M shares, signaling reduced participation; selling pressure persists but buying support remains insufficient.
Valuation & Earnings
Current P/E of 82.05 trades at the 1.6th percentile over three years—historically cheap. While the absolute multiple appears elevated, relative to NOW.US’s high-growth profile and against an industry median of 8.0 (ranked 25th of 53), valuation is clearly discounted.
Earnings deterioration emerged as the key risk: Q2 2026 EPS contracted 21.91% YoY to $0.2889 vs. $0.3700 in Q2 2025; net profit fell 22.6% to $298M from $385M. More concerning: profit collapsed despite accelerating revenue—Q2 revenue of $3,987M grew 24.01% YoY (a recent high), yet earnings plummeted. This suggests margin compression or cost control issues.
Versus consensus: full-year EPS forecast of $4.531 implies management expects strong H2 2026 delivery; however, Q2’s deterioration threatens this trajectory. No analyst has adjusted estimates across five recent snapshots, indicating the rating universe has yet to fully absorb the latest earnings shock.
Capital Flow
Institutional capital showed net inflows ($2.77B in, $1.48B out among large players), but retail (small cap) was slightly positive ($6.03B in, $5.90B out). Mid-cap was modestly long ($3.52B in, $2.87B out). Large-cap institutional inflows signal confidence in long-term prospects, but magnitude is insufficient to support the stock—explaining the disconnect between rising capital and falling price.
Analyst Consensus
Ratings remain overwhelmingly constructive: 35 strong buys and 2 holds of 51 total analysts (>70% buy rating), with only 1 sell. 12-month target price of $143.84 implies 9.7% upside from the prior close of $131.17. No rating changes have been recorded this week; the consensus appears to lag the latest earnings miss.
Contradictions & Warning Signs
Central contradiction: bottom-of-range valuation + high analyst conviction + institutional inflows, yet stock declining with worsening profit metrics. This dynamic typically signals sentiment inflection.
- Profit margin crisis amid revenue growth: 24% revenue expansion masks 22.6% profit contraction, pointing to structural pressure on unit economics.
- Institutional divergence: large-cap inflows insufficient to offset selling pressure suggests internal disagreement or hedging activity among the buy-side.
- Lagging consensus: analyst target prices, released days ago, may anchor overoptimistic expectations; investor caution warranted until management clarifies Q2 profit erosion and Q3 guidance.
Next week, Q3 forward guidance and management commentary on margin trends will be critical.